American Drug Utilizations Review Society
EIN: 731619985 · Edmond, OK · NTEE: S41
| Metric | Value |
|---|---|
| Total Revenue | $282K |
| Total Expenses | $233K |
| Net Assets | $575K |
Is American Drug Utilizations Review Society Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About American Drug Utilizations Review Society
American Drug Utilizations Review Society (EIN: 731619985) is a nonprofit organization based in Edmond, OK, classified under NTEE code S41. The organization reported total revenue of $282K and total assets of $554K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of American Drug Utilizations Review Society's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
American Drug Utilizations Review Society is a small nonprofit that has been operating for 24 years, with 13 years of IRS 990 filings on record (2012–2024). Revenue has grown at a compound annual rate of 4.4%.
Key Financial Metrics (2024)
From the most recent IRS 990 filing on record:
| Total Revenue | $258K |
| Total Expenses | $233K |
| Surplus / Deficit | +$25K |
| Total Assets | $575K |
| Total Liabilities | $7 |
| Net Assets | $575K |
| Operating Margin | 9.8% |
| Debt-to-Asset Ratio | 0.0% |
| Months of Reserves | 29.6 months |
Financial Health Grade: A
In 2024, American Drug Utilizations Review Society reported a surplus of $25K with revenue exceeding expenses, holds 29.6 months of operating reserves (strong position), has a debt-to-asset ratio of 0.0% (very low leverage).
Financial Trends
Over 13 years of filings (2012–2024), American Drug Utilizations Review Society's revenue has grown at a compound annual growth rate (CAGR) of 4.4%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2024 | +8.5% | -32.8% | +10.0% |
| 2023 | -5.0% | +50.7% | -19.3% |
| 2022 | +251.4% | +111.8% | -6.5% |
| 2021 | -70.1% | -47.1% | +10.7% |
| 2020 | +0.0% | -9.1% | -1.5% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2002 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for American Drug Utilizations Review Society has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates American Drug Utilizations Review Society with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2024)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $25K, with revenue exceeding expenses.
- Debt-to-asset ratio: 0.0%.
Frequently Asked Questions about American Drug Utilizations Review Society
Is American Drug Utilizations Review Society a legitimate charity?
American Drug Utilizations Review Society (EIN: 731619985) is a registered tax-exempt nonprofit based in Oklahoma. It has 13 years of IRS 990 filings on record. Total revenue: $282K. No red flags identified. Financial health grade: A.
How does American Drug Utilizations Review Society spend its money?
American Drug Utilizations Review Society reported $282K in total revenue in IRS 990 filings. 13 years of filing data available. Revenue exceeded expenses in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to American Drug Utilizations Review Society tax-deductible?
American Drug Utilizations Review Society is registered as a tax-exempt nonprofit (EIN: 731619985). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is American Drug Utilizations Review Society located?
American Drug Utilizations Review Society is headquartered in Edmond, Oklahoma and files with the IRS under EIN 731619985. It is classified under NTEE code S41.
How many years of IRS 990 filings does American Drug Utilizations Review Society have?
American Drug Utilizations Review Society has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $282K in total revenue.
Filing History
IRS 990 filing history for American Drug Utilizations Review Society showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2012–2024), American Drug Utilizations Review Society's revenue has grown by 66.7%, moving from $155K to $258K. Total assets increased by 48.6% over the same period, from $387K to $575K. Total functional expenses rose by 26.3%, from $184K to $233K. In its most recent filing year (2024), American Drug Utilizations Review Society reported a surplus of $25K, with revenue exceeding expenses. The organization holds $7 in liabilities against $575K in assets (debt-to-asset ratio: 0.0%), resulting in net assets of $575K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2024 | $258K | $233K | $575K | $7 | — | — |
| 2023 | $238K | $347K | $523K | $328 | — | — |
| 2022 | $250K | $230K | $648K | $425 | — | View 990 |
| 2021 | $71K | $109K | $693K | $956 | — | — |
| 2020 | $238K | $205K | $626K | $1K | — | View 990 |
| 2019 | $238K | $226K | $636K | $1K | — | View 990 |
| 2018 | $230K | $202K | $626K | $1K | — | — |
| 2017 | $263K | $210K | $583K | $2K | — | View 990 |
| 2016 | $251K | $208K | $590K | $81K | — | View 990 |
| 2015 | $267K | $206K | $487K | $3K | — | View 990 |
| 2014 | $248K | $195K | $430K | $8K | — | — |
| 2013 | $153K | $168K | $373K | $4K | — | View 990 |
| 2012 | $155K | $184K | $387K | $3K | — | View 990 |
Year-by-Year Financial Summary
- 2024: Revenue of $258K, expenses of $233K, and assets of $575K (revenue +8.5% year-over-year).
- 2023: Revenue of $238K, expenses of $347K, and assets of $523K (revenue -5.0% year-over-year).
- 2022: Revenue of $250K, expenses of $230K, and assets of $648K (revenue +251.4% year-over-year).
- 2021: Revenue of $71K, expenses of $109K, and assets of $693K (revenue -70.1% year-over-year).
- 2020: Revenue of $238K, expenses of $205K, and assets of $626K (revenue +0.0% year-over-year).
- 2019: Revenue of $238K, expenses of $226K, and assets of $636K (revenue +3.6% year-over-year).
- 2018: Revenue of $230K, expenses of $202K, and assets of $626K (revenue -12.5% year-over-year).
- 2017: Revenue of $263K, expenses of $210K, and assets of $583K (revenue +4.9% year-over-year).
- 2016: Revenue of $251K, expenses of $208K, and assets of $590K (revenue -6.2% year-over-year).
- 2015: Revenue of $267K, expenses of $206K, and assets of $487K (revenue +7.7% year-over-year).
- 2014: Revenue of $248K, expenses of $195K, and assets of $430K (revenue +61.8% year-over-year).
- 2013: Revenue of $153K, expenses of $168K, and assets of $373K (revenue -0.9% year-over-year).
- 2012: Revenue of $155K, expenses of $184K, and assets of $387K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for American Drug Utilizations Review Society:
Data Sources and Methodology
This transparency report for American Drug Utilizations Review Society is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.